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N6-methyladenosine (m6A) is acommonmodification
of mRNA with potential roles in fine-tuning the RNA
life cycle. Here, we identify a dense network of pro-
teins interacting with METTL3, a component of the
methyltransferase complex, and show that three of
them (WTAP, METTL14, and KIAA1429) are required
for methylation. Monitoring m6A levels upon WTAP
depletion allowed the definition of accurate and
near single-nucleotide resolution methylation maps
and their classification intoWTAP-dependent and -in-
dependent sites. WTAP-dependent sites are located
at internal positions in transcripts, topologically static
across a variety of systems we surveyed, and
inversely correlated with mRNA stability, consistent
with a role in establishing ‘‘basal’’ degradation rates.
WTAP-independent sites form at the first transcribed
base as part of the cap structure and are present at
thousands of sites, forming a previously unappreci-
ated layer of transcriptome complexity. Our data
shed lighton theproteomicand transcriptional under-
pinnings of this RNA modification.
INTRODUCTION
DNA, RNA, and proteins are all subjected to biochemical modi-
fications following synthesis, which can alter and fine-tune their284 Cell Reports 8, 284–296, July 10, 2014 ª2014 The Authorsfunction by diverse regulatory mechanisms. N6-methyladeno-
sine (m6A) is a highly prevalent base modification occurring on
mammalian mRNA. Recent studies used immunoprecipitation
of methylated RNA fragments followed by sequencing (m6A-
seq) to globally map transcript regions enriched in m6A in
mammalian cells, finding that it is strongly enriched near stop
codons and in long exons (Dominissini et al., 2012; Meyer
et al., 2012).
Conceptually, m6A in mammals has the potential of fine-tun-
ing RNA function in different ways. One possibility is that genes
are subjected to methylation only under specific conditions or in
specific tissues (‘‘condition specific methylation’’), as is the
case in yeast meiosis (Agarwala et al., 2012; Clancy et al.,
2002; Schwartz et al., 2013). A nonmutually exclusive scenario
is that m6A may mark and regulate a specific sets of transcripts
(‘‘transcript specificmethylation’’), for instance, by affecting their
stability (Wang et al., 2014a). To explore potential roles for m6A,
it is necessary to investigate the extent to which m6A varies
across physiologically relevant conditions. To date, mammalian
methylated sites have been mapped and characterized in only a
small number of mammalian cell lines/tissues (Dominissini et al.,
2012; Meyer et al., 2012; Wang et al., 2014a) limiting the ability to
evaluate methylation dynamics. Moreover, the resolution of
these maps was limited, with sites typically being >20 nt away
from the nearest consensus signal, potentially reflecting a
nonnegligible amount of false-positives.
Obtaining accurate maps of mRNA methylation requires iden-
tification of the proteins involved in catalyzing them. We recently
found in yeast that available protocols for m6a-seq identified
both true methylated sites and false-positive sites, and that
these two classes could be distinguished by mapping methyla-
tions that remain after knockout of the methyltransferases
(Schwartz et al., 2013). Until recently, only one protein—METTL3
(Methyl-transferase-like 3)—was implicated in m6A methylation
of mammalian mRNA (Bokar et al., 1997). However, it had
been recognized that additional components were crucial for
methylation (Bokar et al., 1997). While this manuscript was under
preparation, two additional proteins, WTAP and METTL14, were
identified as required for methylation (Liu et al., 2014; Ping et al.,
2014; Wang et al., 2014b). These studies, however, did not study
the extent to which individual sites were dependent on these
proteins, which is important both to eliminate false-positives
(Schwartz et al., 2013) and to identify sites that are methylated
using orthogonal pathways.
Here, we have employed an unbiased proteomic approach to
characterize the components of the methyltransferase complex,
allowing us to identify and validate known and unknown compo-
nents required for methylation. By mapping sites upon experi-
mental depletion of these components, we were able to classify
and characterizemethylated sites based on their dependency on
these proteins. Our analyses provide important resources at the
proteomic and transcriptomic levels toward understanding the
regulators (‘‘who’’) and targets (‘‘where’’) of RNA methylations,
two crucial milestones toward addressing the function (‘‘why’’)
of this epitranscriptomic modification.
RESULTS
Proteomic Screens Identify Components of the
Methyltransferase Complex
To identify components of the human m6A methyltransferase
complex, we performed coimmunoprecipitation (co-IP) experi-
ments with an overexpressed C terminus HIS-tagged METTL3
in HEK293 cells, followed by LC-MS/MS (Experimental Proce-
dures). After filtering out background contaminants using the
CRAPOME database (Mellacheruvu et al., 2013) (Experimental
Procedures), one of the most enriched proteins was WTAP, the
human ortholog of Mum2, a crucial component of the yeast
methyltransferase complex (Agarwala et al., 2012; Schwartz
et al., 2013) (Figure 1A). Proteins interacting with WTAP have
recently been characterized in a proteomic screen (Horiuchi
et al., 2013). Analysis of this data revealed reciprocal binding
of WTAP to both METTL3 and to METTL14, a close paralog of
METTL3 (Bujnicki et al., 2002). Confirming this association,
both METTL3 and WTAP were enriched when we performed
mass-spectrometry following pulling down on a 30 terminus V5-
tagged version ofMETTL14 (Figure 1B). The physical association
of METTL14 and WTAP with METTL3, and our previous findings
that all three proteins have tightly coevolved (Schwartz et al.,
2013), thus strongly implicated them in mRNA methylation.
To explore additional proteins involved in the methylation pro-
gram, we used in vitro transcribed biotinylated baits, which were
either methylated or nonmethylated at a single position, to cap-
ture proteins from HEK293 protein lysates, followed by quantita-
tive LC-MS/MS (Figure 1C). YTHDF1, YTHDF2, and YTHDF3,
three proteins from the YTH domain family, were the top three
enriched proteins in this screen. This enhances our previous re-
sults (Dominissini et al., 2012), where two of these three proteinswere identified as m6A binders (Dominissini et al., 2012), and is
consistent with recent biochemical results showing that these
three proteins all selectively bind m6A (Wang et al., 2014a).
Interestingly, the fourth most enriched protein in this assay
was WTAP, suggesting that WTAP may be involved not only in
mediating methylation, but also in binding it.
Finally, we used a V5-tagged version of each of three YTH
proteins in affinity proteomics. These experiments highlighted
potential associations between different YTH proteins (e.g., be-
tween YTHDF1 and YTHDF2) or between the YTH proteins and
other components of the methyltransferase machinery identified
here (e.g., YTHDF2 and WTAP, YTHDF1, and METTL3). The full
proteomics data sets are available in Table S1.
Integrating the proteomic data into a network (Figure 1D;
Experimental Procedures) highlights the centrality of WTAP
and METTL14 in this complex, consistent with the three recent
reports (Liu et al., 2014; Ping et al., 2014; Wang et al., 2014b).
The density and topology of the network suggest that the con-
ceptual distinction between m6A ‘‘writers’’ and ‘‘readers’’ may
not be clear cut, because the putative writers (METTL3, WTAP,
METTL14) and readers (YTH proteins) may physically interact
with each other. Finally, 13 proteins with diverse functions
interact with two or more of the seven core components studied
here and may therefore form part of the methyltransferase com-
plex as well. However, we cannot rule out that some of these
associations may be spurious, and each of these candidates
will therefore have to be individually tested. Below we validate
three of these proteins.
WTAP Is Necessary for m6A mRNA Methylation
To determine whether WTAP is required for mRNA methylation
in vivo, we depleted it in p53/ mouse embryonic fibroblasts
(MEFs) using WTAP-targeting small hairpin RNAs (shRNAs) to
10%–15% of WT levels (Figures S1A–S1D). We used anti-
hnRPDL and anti-GFP shRNAs as negative controls. We immu-
noprecipitated and sequenced methylated RNA from these
samples using an m6a-seq procedure, optimized for enhanced
resolution and scalability using decreased starting material
(Schwartz et al., 2013). Analyzing these profiles (Experimental
Procedures), we identified 16,487 putative m6A sites, present
in at least two of the eight profiled conditions.
Most sites (10,609/16,487, 64.3%) were WTAP dependent
(‘‘WTAP-dependent’’ cluster), showing dramatically decreased
methylation Peak Over Input (POI) scores compared to any of
the controls (p < 2.23 1016 for all comparisons, Mann-Whitney)
following knockdown with either of two shRNAs targeting
different regions of WTAP (Figure 2A). WTAP-dependent sites
were strongly enriched for hallmarks of m6A methylation: sites
were within a median distance of 5 nt from the nearest
consensus site (Figures 2B, S1E, and S1F); 34.6% of sites
were within 200 nt of the stop codon (Figure 2C); and median in-
ternal exons harboring sites in this cluster tended to be 7-fold
longer than nonmethylated exons (Figure 2D).
The remaining sites formed two distinct clusters (Figure 2A),
neither of which was enriched for the methylation consensus
signal (median distances to consensus motif were 27 and
38 nt, respectively), or for any of the other hallmarks of m6A
methylation (Figures 2B–2D). One of these two clusters showedCell Reports 8, 284–296, July 10, 2014 ª2014 The Authors 285
Figure 1. Proteomic Identification of Methyltransferase Complex Components
(A and B) Proteins associated with HIS-tagged METTL3 (A) and V5-tagged METTL14 (B). Fold changes quantifying enrichment versus control (Experimental
Procedures) across two biological replicates.
(C) Proteins associated with biotinylated, methylated RNA baits, compared to biotinylated, nonmethylated counterparts, in two biological replicates.
(D) Network of associations with the bait proteins (shaded gray nodes) identified in the different mass-spec experiments. An edge from bait A to target B indicates
that B was enriched (fold change >1.5) when performing IPs on A. Only target nodes with an incoming degree R2 are displayed. Edge width distinguishes
association between baits (thick lines) and with nonbaits (thin lines). Edges are colored in dark red if they were enriched by a protein bait involving anm6a ‘‘writer’’
(METTL3/METTL14/WTAP), cyan if they were enriched by a ‘‘reader’’ (YTHDF1/YTHDF2/YTHDF3), or dark blue if they were enriched with a methylated bait. The
node for KIAA1429, further analyzed functionally, is marked by a thicker border.dramatic enrichment for sites near the TSS, with 50% of the
sites within 200 nt of the TSS (‘‘TSS-enriched cluster’’); we
show below that the sites in this cluster represent methylations
on the first transcribed nucleotide as part of the cap structure.
The other cluster did not exhibit such dramatic enrichment for
the TSS segment but was pervasive across all sampled condi-
tions and showed no enrichment for the m6A consensus motif.286 Cell Reports 8, 284–296, July 10, 2014 ª2014 The AuthorsThese properties were reminiscent of a set of false-positive sites
that we found in yeast when performing the same m6a-seq pro-
tocol to strains lacking a functional methyltransferase (Schwartz
et al., 2013). Indeed, sequence analysis revealed that the sites in
the cluster (‘‘false-positive cluster’’) were highly enriched for the
same degenerate purine-rich motif (‘‘AGAAGAA’’) that we found
at the yeast false-positive sites (Figures S1G and S1H). In yeast,
we have previously shown that these sites were false-positive
sites enriched in a nonspecific manner during the immunopre-
cipitation process, because they are enriched even when we
perform m6A-seq with in vitro synthesized sites without any
methylations (Schwartz et al., 2013); thus, we considered it
highly likely that these sets of sites are false-positives and
conservatively opted to either analyze them separately, or elim-
inate them altogether, in the subsequent analyses.
We confirmed these results in human A549 cell lines where
WTAP was perturbed using either shRNAs (Figure 2E) or
siRNAs (Figure 2F). We observed a similarly strong reduction of
methylation upon WTAP depletion in both sets of experiments,
and clustering of the detected sites yielded very similar clusters
to those obtained in the mouse studies above (Figures 2E and
2F), with similar characteristics (Figures S1I–S1K).
KIAA1429 Is Required for mRNA Methylation
Of the other 13 candidates associating with methyltransferase
components in our proteomics screen (Figure 1D), we focused
our attention on KIAA1429 because its Drosophila ortholog
was biochemically shown to interact with Drosophila WTAP in
the context of sex-specific splicing (Ortega et al., 2003). We
used siRNAs to deplete KIAA1429 in human A549 cells to
6% of WT levels (Figure S1C) and performed m6A-seq on the
resulting cells. We observed a median 4-fold decrease
(Mann-Whitney, p < 2.2 3 1016) in peak scores compared to
cells treated with nontargeting siRNAs (Figure 2F). Although
these decreases were less dramatic than those observed
upon knockdown of WTAP (median decrease: 6.25-fold), they
were substantially and significantly (Mann-Whitney, p < 2.2 3
1016) more prominent than observed upon knockdown of either
METTL3 or METTL14 (see below), demonstrating that KIAA1429
is required for the full methylation program in mammals.
KnockdownofMETTL3 and/orMETTL14 Leads toMilder
Decreases in Methylation Levels
We next used shRNAs and siRNA to test the effect of depleting
METTL3 andMETTL14 inmouse fibroblasts (METTL3, Figure 2A)
and in human A549 cells (both, Figures 2E and 2F). In mouse, we
observed a moderate depletion of m6A levels for one of the hair-
pins (shMETTL3-2, where METTL3 transcript was reduced to
10% of WT levels), but not for another (shMETTL3-3, where
knockdown efficiency was lower) (Figure S1A). In human,
shRNA-mediated knockdown of METTL3 levels to 10% of
WT levels did not reveal a discernible effect on m6Amethylation,
but use of siRNAs, which enabled even higher knockdowns
(5% of WT levels, Figures S1C and S1D), yielded POI scores
that were reduced to 60% of control (Mann-Whitney, p < 2.2 3
1016, Figure 2F). Similarly, for METTL14 knockdown, we failed
to observe an effect when knocking it down using shRNAs to
20% of WT levels (Figure S1B), but upon knocking it down
to 6% with siRNAs (Figure S1C) we observed reductions to
similar levels as for METTL3 (median decrease: 51% of control).
Similar levels were achieved also with dual knockdown of
METTL3 and METTL14 (median decrease: 53% of control, Fig-
ure S1C). Our results, which are consistent with Liu et al.
(2014), demonstrate a strong threshold dependence for both
METTL3 and METTL14, which is likely due to adequacy ofeven low levels of METTL3 and METTL14 to mediate mRNA
methylations.
Bulk Measurements of m6A Levels Highly Consistent
with m6A-Seq
To further confirm our results, we used HPLC-M/S to measure
bulk levels of m6A in poly(A) mRNA from A549 cells upon
siRNA-mediated knockdown of the above genes (Figure 2G).
Consistently, highest levels of depletion in m6A content in the
oligo-dT selected poly(A) fraction were obtained for WTAP
(5.6-fold depletion), followed by KIAA1429 (3-fold), followed
by single or combined knockdown of METTL3 and METTL14
(1.9- to 2.5-fold). M6A levels in the flowthrough fraction were
roughly equal for all samples (Figure 2G). These results were ex-
pected, because the flowthrough is dominated by rRNA, which
harbors m6A at nonconsensus positions (Liu et al., 2013; Mach-
nicka et al., 2013) that are likely deposited by proteins distinct
from the ones identified here.
A High-Quality, High-Resolution Catalog of the m6A
Methylome across Four Dynamic Systems
To date, mammalian methylated sites have been mapped and
characterized in only a limited number of cell lines and tissues.
To determine the extent to which m6A methylation may be
modulated in physiologically relevant contexts, in both mitotic
and postmitotic cells, we mapped methylation across four
distinct dynamic systems in human and mouse: (1) mouse
bone-marrow-derived dendritic cells (BMDCs) responding to
lipopolysaccharide (LPS), (2) mouse embryonic (e16) and adult
brains, a system chosen based on previous reports of lower
levels of bulk m6A in embryonic brain (Meyer et al., 2012), (3)
human fibroblasts undergoing reprogramming into induced
pluripotent stem cells (iPSC) following doxycycline-induced
expression of polycistronic OCT4-KLF4-MYC-SOX2, and (4)
human embryonic stem cells undergoing differentiation into
NPCs (Figure 3A).
Integrating all m6A profiles yielded 40,742 sites in human and
31,423 in mouse, present in at least two conditions, tripling
the reported number of detected putative methylation sites
compared to previous studies.We classified each site as high, in-
termediate, or low confidence based on a linear combination of
three features: (1) number of samples in which peak was identi-
fied, (2) extent of dependency on WTAP, and (3) maximal POI
score observed across any of the samples. The features were
selected as informative based on distance to nearest consensus
site (Figure S2A; Experimental Procedures), and the resulting
ranking was independently consistent with enrichment of sites
in long exons (Figure S2B) and near stop codons (Figure S2C).
Thesites identifiedhereareat adramatically increased resolution,
comparedwith previous studies, with 50%of the top 15,000 sites
being within 5–6 nt from the nearest consensus site, in both data
sets. The full set of sites is provided (Table S2) allowing custom
filtration of the data based on user-defined criteria.
WTAP-Dependent Sites Have a Static Topology across
Multiple Dynamic Systems
Although initial examination suggested the presence of many
condition-specific methylations, closer examination indicatedCell Reports 8, 284–296, July 10, 2014 ª2014 The Authors 287
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that observed differences were largely due to changes in under-
lying gene expression. For example, in themouse data set, 3,629
sites classified as ‘‘high’’ or ‘‘intermediate’’ are present only in
the two brain samples, and 1,312 such sites are present exclu-
sively in the DCs. However, these differences clearly reflected
the expression levels of the genes harboring the sites (Figures
S2D and S2E), which indeed were enriched for genes involved
in neural processes and immune response, respectively (Figures
S2F and S2G).
To reliably compare sites across samples despite different
expression levels, we therefore conservatively limited our anal-
ysis to a subset of WTAP-dependent sites within genes ex-
pressed above the 60th percentile in all samples, resulting in
11,247 sites in human (Figure 3B) and 8,456 sites in mouse (Fig-
ure 3C). Dividing these into three equally sized sets based on
their maximal POI scores across all samples, we found that
among the highest scoring sites >90% of the sites in human
(Figure 3D) and >98% of the sites in mouse (Figure 3E) were de-
tected as enriched (POI >4) across all samples. Among lower
scoring sites, cases of peaks being called in one condition but
not in another weremore common (Figures 3D and 3E); however,
upon manual inspection of such putative differential sites, it
was difficult to identify convincing sites present in one condition
and absent from another. Rather, such differences were typically
due to subthreshold peaks not being called in a particular sample
or insufficient coverage in a particular region. Indeed, the vari-
ability of POI scores across the different dynamic sets of
conditions was similar to the variability across different experi-
ments performed in the same cell line (MEFs in mouse, A549 in
human) (Figures S2H and S2I). Thus, overall methylation profiles
appear to be similar across diverse conditions, at least under
our conservative criteria, suggesting that in mammals m6A
plays a basal, ubiquitous role, shared across different cell types
and systems. However, because m6A-seq cannot directly
quantify methylation levels, our approach may be blind to quan-
titative differences in methylation levels between samples (see
Discussion).
WTAP-DependentMethylation Inversely Correlateswith
mRNA Stability and Is Depleted in Housekeeping Genes
Because we found little evidence for condition-specific differ-
ences in methylation, we next sought to analyze the potential
of a transcript-specific role. Examining the relationship betweenFigure 2. Perturbation of Methyltransferase Complex Components Ide
(A) K-means clustering of log2 transformed peak over input scores (yellow, high;
(MEFs). Only sites detected in two or more of the presented samples (columns), wi
above the 60th percentile are shown. Sites were initially clustered into five clusters
with existing clusters, based on similarity of characteristics, to yield three clusters
capped at 4.5 and then transformed into Z scores. The internal shRNA identifiers
(B) Distributions of distance from the nearest consensus site of the sites in the th
(C) Distribution of the sites in (A) grouped by the clusters in (A) across five gene
(D) Distribution of length of internal exons across the clusters identified in (A).
(E) K-means clustering of log2 transformed Peak Over Input scores across 17,33
(F) K-means clustering of log2 transformed Peak Over Input scores for set of expe
are WTAP-dependent sites (rows) within genes expressed above the 60th percen
(G) Relative m6A/A ratios across A549 cells treated with siRNA as indicated, asme
the flowthrough (orange).
(H) Examples of coverage from IP (blue) and input (red) experiments across selecgene-level attributes and methylation densities (number of
WTAP-dependent methylation sites normalized by gene length)
in mouse, we noted that the top 20% of expressed genes were
significantly less likely to be methylated compared to more lowly
expressed genes (Figure 4A). Indeed, genes completely lacking
methylation sites are highly enriched for those involved in
‘‘housekeeping’’ cellular processes like translation, mitochon-
drial-related processes, chromatin regulation, and splicing. To
study this further, we examined the proportion of genes lacking
methylations across all Gene Ontology (GO) categories in
human, mouse, and yeast. This analysis revealed that the func-
tional group ‘‘structural constituents of ribosome’’ ranked high-
est in proportion of genes lacking methylation in both human
and mouse, and second highest in yeast (Figure 4B). Other
groups of housekeeping genes ranking high in both yeast and
mammals include splicing and GTPase activity (Figure 4B).
Thus, lack of methylations among ribosomal proteins, in partic-
ular, and specific sets of housekeeping proteins, in general, is
conserved between yeast and mammals.
Because housekeeping genes generally have shorter mRNAs
with shorter CDSs and UTRs and fewer exons (Eisenberg and
Levanon, 2003) and longer RNA half-lives (Schwanha¨usser
et al., 2011), we directly examined the correlation between
each of these variables and methylation densities (Figures 4C
and 4D). Strikingly, the variable correlating most strongly with
methylation density was mRNA half-life (Figures 4C–4E), as pre-
viously estimated in mouse fibroblasts (Schwanha¨usser et al.,
2011) (Spearman r =0.27, p = 1.23 1069), and this correlation
remained of similar magnitude (r = 0.22) when performing this
analysis after eliminating the top 10% or top 20% of genes,
ranked by expression levels. Consistently, examining the differ-
ence in proportion of variance explained (R2) when predicting
methylation densities from all these variables, compared to
exclusion of any single one, revealed that mRNA half-life
accounted for the greatest difference (Figure 4D). We obtained
similar results when performing these analyses for human
transcripts using transcript stability estimates in human lympho-
blastoid cell lines (Duan et al., 2013) (Figures S3A and S3B), with
half-life exhibiting the strongest correlation with methylation
density (Figure S3C), albeit at somewhat reduced levels
(r = 0.14, p = 3.4 3 1034). Our results are consistent with re-
ports implicating methylations in mRNA degradation (Wang
et al., 2014a, 2014b) and suggest that m6A methylation mayntifies Complex-Dependent and -Independent Methylation Sites
blue, low) across 16,487 sites (rows) detected in mouse embryonic fibroblasts
th amaximal Peak Over Input score greater than 8, and within genes expressed
using k-means, and three of the clusters were subsequently manually merged
(separated by black lines). For visualization purposes, the log2(POI) scores were
are indicated in parentheses.
ree clusters in (A).
segments, defined as in Dominissini et al. (2012).
1 sites (rows) detected in human A549 cells, visualized as in (A).
riments involving perturbations of A549 cells with siRNAs, as indicated. Plotted
tile across all conditions.
asured by HPLC-M/S. Values are plotted for both the poly(A) fraction (blue) and
ted genes in A549 cells treated with shGFP (top row) or shWTAP (bottom row).
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help set a basal degradation program, and that highly abundant
messages might have evolved to maximize their stability by
avoiding mRNA methylation.
WTAP-Independent m6A Methylome at the mRNA Cap
Studies in the mid-1970s involving bulk analysis of mRNA caps
revealed that when the first nucleotide of a transcript is an aden-
osine this base can be methylated at the N6 position (Furuichi
et al., 1975; Keith et al., 1978; Wei et al., 1975). However, no
study to date has been able to resolve which mRNA caps within
which messages are methylated. We hypothesized that the
consistently observed WTAP-independent peaks enriched near
the TSS (Figures 2A, 2E, and 2F) reflect methylations occurring
at the cap. Corroborating this hypothesis, we found that 30.5%
of the mouse genes expressed above the 60th percentile with
a ‘‘TSS peak’’ (i.e., an m6A peak within the first 200 nt) are
annotated to begin with an ‘‘A’’, compared to only 23% of the
genes lacking a peak (Fisher’s exact test, p = 2.8 3 1013),
consistent with analyses performed in Dominissini et al. (2012).
Although this enrichment was significant, it did not explain the
peaks observed in the remaining 70% of the genes.
We therefore considered the 70% of genes whose RNA
transcripts harbored a TSS peak but whose annotated TSS
did not contain an ‘‘A’’ at the first base. We suspected that
many of these cases might reflect limitations of the genomic
annotation, as transcription initiation often occurs from a
variety of closely spaced positions (Carninci et al., 2006; Ni
et al., 2010; Plessy et al., 2010). We therefore leveraged the
fact that our library construction method relies on ligation of
adapters to both ends of the captured RNA fragment, such
that although each transcript is fragmented ‘‘randomly,’’ every
transcript should yield some fragment beginning at its 50
terminus, resulting in a ‘‘pileup’’ of reads beginning at the 50
terminus of genes. Thus, these pileups harbor information on
the precise transcript initiation sites. Moreover, methylated
transcription start sites (mTSSs) should have a high ratio
between the size of these pileups in the IP sample compared
to the input sample; sites with high ratios should therefore be
highly enriched toward harboring an adenosine, as opposed
to typical transcription start sites that tend to begin with a
guanosine (Carninci et al., 2006).
To detect methylated transcription start sites (mTSSs), we
compared the number of reads stacks beginning at each of the
first 50 annotated positions in the transcript in the IP and input
samples (Experimental Procedures). We assembled a catalog
of 33,714 sites in mouse with evidence of greater than ten reads
beginning at a specific site (across all conditions) and assigned
each site a fold change corresponding to its enrichment in IP
over input. As expected, we found that sites with stronger foldFigure 3. A Human and Mouse Catalog of Methylation Dynamics
(A) Scheme depicting the four experimental systems profiled in this study. Top
reprogramming to iPSCs. Bottom left: human embryonic stem cells undergoin
dendritic cells stimulated by lipopolysaccharide (LPS). Bottom right: embryonic
(B and C) Heatmaps of POI scores (visualized as in Figure 1A) of all WTAP-dep
expressed above the 60th percentile across all conditions (Experimental Procedu
(D and E) Number of conditions (x axis, of a total of seven, as in [B] and [C], respect
sites are identified as present (POI >4). Sites were grouped into three equally sizchanges were also dramatically more likely to harbor an adeno-
sine either at the detected site or at the position immediately pre-
ceding it, with >80% of the sites harboring an adenosine in the
bin of most highly enriched sites (Figure 5A). (The tendency for
adenosines at the position preceding the pileups is likely due
to reverse transcriptase drop-off one base prior to the TSS, as
supported by several lines of evidence [Supplemental Discus-
sion; Figures S4A and S4B; and below].) Further corroboration
of the validity of the detected sites was obtained from an obser-
vation of a strong bias toward pyrimidines at position 1 and a
discernible TATA box 30 bp upstream of the detected sites,
two hallmarks of transcription initiation sites (Carninci et al.,
2006) (Figure 5B).
Our predicted mTSSs also agree well with the results of cap
analysis of gene expression (CAGE) data. We performed the
above analyses in human (obtaining highly similar results; Fig-
ure S4C) and focused on a subset of 9,757 putatively methylated
TSSs (mTSSs) that were independently detected in at least two
experiments in A549 cells, exhibiting at least 4-fold enrichment
in IP over input and harboring an adenosine at either the position
harboring the read stacks or the one preceding it. We compared
these sites to CAGE data in A549 cells, obtained from the
ENCODE project (Bernstein et al., 2012). Of the 9,757 sites,
7,255 (74%) were supported by at least two CAGE tags,
compared to only 34.6% among an equally sized set of random
controls (Fisher’s exact test, p < 2.23 1016). To confirm that the
positions harboring the adenosines (‘‘adenosine positions’’)
were the true TSS evenwhen they preceded the observed stacks
by one base (‘‘stack position’’) (a phenomenonwe attribute to RT
drop-off), we examined a subset of 4,879 sites inwhich the aden-
osine positions preceded the stack positions. Although 80.5%of
the ‘‘adenosine positions’’ were supported by at least two CAGE
tags, only 36.8% of the ‘‘stack positions’’ were supported by
CAGE data, similar to the 34.5% overlap obtained in the random
data set (Figure 5C). Moreover, there was a >6-fold increase in
the mean number of CAGE tags supporting the ‘‘adenosine
positions,’’ compared to either the ‘‘stack positions’’ or the
random positions (Figure 5D). Finally, when restricting this anal-
ysis to positions other than the first annotated position, these re-
sults were essentially identical (data not shown). Together, this
confirms that our approach can identify transcription initiation
sites at single nucleotide resolution and that mTSSs can be reli-
ably detected also within a large number of positions other than
the annotated TSS.
Based on these analyses, we compiled a catalog of putatively
methylated transcription start sites (mTSS), comprising all
unique adenosine-containing sites enriched >4-fold in at least
one condition, encompassing 15,961 sites from 6,454 mouse
genes and 12,601 sites from 5,774 human genes (Table S4).left: doxycycline-inducible OKMS (OCT4, KLF4, MYC, and SOX2) fibroblast
g differentiation to neural progenitor cells. Top right: bone-marrow-derived
and adult mice brain.
endent sites (rows) identified in one or more sample (columns), within genes
res) in human (B) or mouse (C).
ively, excluding any genetic perturbations) in human (D) andmouse (E), in which
ed groups, based on POI score.
Cell Reports 8, 284–296, July 10, 2014 ª2014 The Authors 291
Figure 4. Methylations Are Depleted from Housekeeping Genes and Associated with Decreased Transcript Stability
(A) Association between gene expression and methylation density in MEFs.
(B) TopGOcategories harboring nonmethylated genes in human (top), mouse (middle), and yeast (yeast). Shown is the proportion of nonmethylated genes in each
category. Only genes expressed >60th percentile and longer than 500 nt and only GO categories harboring >30matches genes were considered for this analysis.
(C)Correlations (Spearmanr, x axis) betweendifferentgeneattributes (yaxis) andmethylationdensity.Transcripthalf-liveswereobtained fromSchwanha¨usser etal.
(2011). We used only sites defined in A549 cells (Figure 2E), in protein coding genes longer than 500 nt and expressed above the 60th quantile, with amaximumPOI
score>8,with at least 50% increasedPOI score in nonperturbed cells compared toWTAP-depleted cells, andwhichwere in segments other than the TSSsegment.
(D) Analysis examining the difference in variability explained (R2, x axis) upon elimination of each of the indicated variables from a linear regression model
predicting methylation density on the basis of all of them.
(E) Association between mRNA half-lives (Schwanha¨usser et al., 2011) and methylation densities. Half-lives were binned into ten equally sized bins, and mean
methylation densities for each bin were calculated. Error bars represent the SEM.Many sites—and particularly sites with stronger associated fold
changes—were shared acrossmultiple conditions (Figures S4D–
S4F), and 51% of the above genes in mouse (23% in human) had292 Cell Reports 8, 284–296, July 10, 2014 ª2014 The Authorsmore than one detectedmTSS across all conditions. Limiting this
analysis to a single condition, on average 13% of the transcripts
had more than one mTSS in both mouse and human (e.g.,
Figure 5. Identification of Methylated Transcription Start Sites
(A) Proportion of sites harboring an adenosine (y axis) at the detected position (dark green bars) or the position immediately upstream (light green bars) in 33,714
sites with greater than ten reads within 50 nt of annotated TSSs. Sites were binned based on fold changes (IP over input; x axis), using thresholds as indicated.
(B) Sequence logo for a set of 3,445 putative mTSSs with a log2 fold change exceeding 4.5. The position of the putative methylated mTSS is indicated, and of a
TATA box signal located 30 bp upstream.
(C) Proportion of putativemTSSs supported by two ormore CAGE tags (y axis) for a subset of 4,879 sites, in which the ‘‘adenosine’’ position precedes the ‘‘Stack’’
position. Proportions are shown both for the adenosine position (pink bar), the stack position (cyan), and 4,879 positions randomly assigned to the same set of
genes within the first 50 nt (gray bar).
(D) Distributions of the log10 transformed number of CAGE tags observed for the three groups defined in (C).
(E and F) Examples of genes with multiple internal mTSSs in human iPSCs. Number of reads beginning at each of the first 50 annotated positions in the IP (blue)
and input (red) sample are shown. Detected mTSSs are highlighted in gray and marked with a black arrow; putative penultimate-base RT drop-offs are indicated
with a purple arrow.Figures 5E and 5F). Evaluation of the number of mTSSs found as
a function of gene expression revealed that mTSS detection in
our data has not reached saturation (Figures S4G and S4H),
and thus the numbers reported here most likely reflect a lower
bound.
To gain insight into the potential role(s) of mTSSs, we exam-
ined the extent to which mTSS presence in a gene was associ-
ated with gene structure, RNA stability, and translational
efficiency features. Because our ability to detect mTSSs is
biased toward more highly expressed genes, we used a
randomly sampled control data set matching the expression pat-
terns of the mTSS harboring genes (but lacking mTSSs). We
found that the presence of mTSS is significantly inversely corre-lated with 50 UTR length in both mouse and human (Figures S5A
and S5E) and positively correlated with translation efficiency
(Figures S5A, S5B, and S5F–S5H). However, in contrast to inter-
nal methylation, mTSSs were not associated with transcript sta-
bility (Figures S5A and S5B; see also Supplemental Discussion).
These results may suggest that mTSSs and internal methylation
sites may differ both in the factor(s) mediating their catalysis, and
in their function, with internal sites potentially affecting stability
and mTSSs potentially affecting translation. However, because
these results are based on comparison between different tran-
scripts, which may vary from each other in other respects that
could potentially correlate with mTSS state, they must be inter-
preted with care. The presence and abundance of the mTSSCell Reports 8, 284–296, July 10, 2014 ª2014 The Authors 293
identified here add an additional unappreciated layer of
complexity to the mammalian transcriptome, suggesting that a
substantial fraction of transcripts exist in distinct isoforms,
differing not only in the location of the TSS but also in its methyl-
ation state. It will be crucial to develop experimental methodolo-
gies to specifically perturb the methylation state of individual
transcripts, and to monitor the impact of such perturbations on
various stages of an RNA’s life cycle, to conclusively understand
the role of mTSSs.
DISCUSSION
The m6A Methylation Landscape
RNA methylations offer the potential of dynamically modulating
characteristics of an mRNA’s life cycle. Such regulation may
potentially be applied either in specific conditions, or to specific
transcripts, two scenarios that we set out to explore. Bymapping
methylations across various dynamic systems in human and
mouse, we were able to more than triple the number of sites pre-
viously identified for either human or mouse (Dominissini et al.,
2012; Meyer et al., 2012), while simultaneously enhancing the
resolution of the detected sites, to nearly single-nucleotide level.
We found that across the monitored conditions methylations
appeared to be largely static, suggesting that the role of m6A
inmammals is to a large extent condition independent. These re-
sults should best be interpreted with caution, because it is
possible that m6a-seq is unable to capture subtle, quantitative
differences in the proportion of transcripts methylated at a spe-
cific position, which could still be of functional consequence. To
better assess the extent to which m6A is quantitative, measure-
ments by orthogonal methods, such as the recently developed
SCARLET (Liu et al., 2013), will be required for a large number
of sites.
Although the topology of WTAP-dependent methylations is
relatively static across mRNAs, we find that their distribution
across genes is not uniform, and that methylations are depleted
from abundantly transcribed messages. We moreover find that
methylation densities correlate inversely with mRNA half-life.
These findings are consistent with recent findings that YTHDF2
binds to methylated mRNAs and decreases messenger stability
(Wang et al., 2014a), and with the fact that transcript half-lives
are generally constant across different conditions. Indeed, in
DCs, we do not see any change in m6A densities for those
15% of transcripts where degradation rates change dynami-
cally in response to LPS (data not shown). Collectively, our re-
sults suggest that internal m6A sites may play a ‘‘basal’’ role in
controlling the half-lives of the methylated transcripts, and that
this role is relatively constant across the different surveyed
conditions.
The Multicomponent Methyltransferase Complex
Initial characterization of the mammalian methyltransferase
complex revealed that at least two separable complexes (875
and 200 kDa in size) were required for restoring full m6A activity
in vitro (Bokar et al., 1994). Subsequent analysis identified
METTL3 as one of the components in the smaller complex
(Bokar et al., 1997). Here, we show that WTAP, KIAA1429, and
METTL14 are required for full m6A activity in vivo. The multiunit294 Cell Reports 8, 284–296, July 10, 2014 ª2014 The Authorsstructure of the m6A methyltransferase is unique with respect
to other characterized nucleic acid methyltransferases (Bokar
et al., 1994), and offers the potential for complex regulation.
Such is the case in yeast where onset and offset of methylations
in meiosis were governed by up/downregulation of different
members of this complex at different time points in meiosis
(Schwartz et al., 2013).
Our results regarding WTAP andMETTL14 are consistent with
recently published results (Liu et al., 2014; Ping et al., 2014;
Wang et al., 2014b), whereas KIAA1429 was not identified
by these studies. The physical association of KIAA1429 with
the methyltransferase complex is supported by the physical
association of Drosophila homologs of KIAA1429 (virilizer) and
WTAP (fl[2]d) in the context of female-specific alternative splicing
(Granadino et al., 1990). Moreover, KIAA1429 in human localizes
to the nuclear speckles (Horiuchi et al., 2013), as do METTL3
(Bokar, 2005) and WTAP (Horiuchi et al., 2013; Little et al.,
2000), further supporting their association with each other. We
identified another 13 proteins interacting with two or more of
the above components. This collection may contain false-posi-
tives, and it will therefore be important to experimentally validate
them via similar strategies.
The expression patterns of the different methyltransferase
components offer important clues about the processes in which
they are implicated. The yeast WTAP homolog, Mum2 is ex-
pressed in a meiosis-specific manner (Agarwala et al., 2012;
Schwartz et al., 2013) and required for proper progression of
meiosis (Davis et al., 2001). In Drosophila, fl(2)d and virilizer are
both expressed at highest levels in the ovaries and brain (Robin-
son et al., 2013). Analysis of METTL14 expression levels across
the Illumina Human Body Map (Farrell et al., 2014) also reveals
particularly high levels of expression in testis and ovaries. These
observations, combined with previous findings that ALKBH5, an
m6A demethylase, is expressed at highest levels in the testis and
required for spermatogenesis (Zheng et al., 2013), suggest that
the methyltransferase complex may have an evolutionary
conserved role in mammalian gametogenesis. Nonetheless,
the ubiquitous expression of mammalian WTAP and KIAA1429
across tissues and ubiquitous presence of m6A suggests that
this modification has acquired additional roles in mammals.
Rich Landscape of m6A at the mRNA Cap
In higher eukaryotes, but not in yeast, the 50 cap structure con-
tains 20-O-ribose methylations at either the first nucleotide or
the first and second nucleotide (Wei et al., 1975). When the first
nucleotide of the transcript is an adenosine, this base can be
methylated at the N6 position (Furuichi et al., 1975; Keith et al.,
1978; Wei et al., 1975). However, no studies to date have
resolved the methylation states of the caps of specific tran-
scripts. Here, we simultaneously measured transcription initia-
tion sites and their methylation status at thousands of sites and
found that the transcription initiation landscape is highly com-
plex, with transcript isoforms differing from each other in their
methylation states. Our findings that mTSS state at the cap is
correlated negatively with 50 UTR length and positively with
translation efficiencies suggest that the process most likely to
be affected by mTSSs is translation. To investigate this more
thoroughly, it will be necessary to better understand the
enzymatic components involved in cap methylation (Keith et al.,
1978), and to develop targeted methodologies for monitoring
and perturbing methylation status at the cap.
The ubiquity of m6A across dramatically different cell types
and systems, the conservation of the different components
involved in mediating and binding it across most studied sys-
tems, and the phenotypes associated with its depletion all
suggest a fundamental role in mammalian cell biology. The
rich proteomic and transcriptomic resources we provide in this




Human embryonic kidney 293T cells were transfected with plasmids encoding
30 tagged proteins (Table S4) using Lipofectamine 2000 (Life Technologies).
Pull-down was performed with anti-HIS (GenScript) or Anti-V5 (Life Technolo-
gies) antibodies. siRNAs (Thermo Scientific) were delivered using Lipofect-
amine RNAiMAX (Life Technologies); shRNAs (Broad RNAi Consortium) were
delivered in polybrene supplemented media and selected for 72–96 hr. Details
regarding derivation/culturing of HUES9, neural progenitors, mice brain sam-
ples, BMDCs, and hTERT immortalized fibroblasts reprogrammed into iPSCs
are in Supplemental Experimental Procedures.
Mass Spectrometry Data Analysis
Details pertaining mass spectrometry data acquisition are in Supplemental
Experimental Procedures. All mass spectra were processed using the Spec-
trum Mill software package v4.0 beta (Agilent Technologies) according to
(Mertins et al., 2012). For each peptide, a log2 fold change was calculated be-
tween its intensities in the pull-down sample compared to the control. The
peptides were mapped to genes based on the Uniprot database, and the me-
dian fold change was assigned to each gene. We then subtracted the median
of the distribution of the log2 transformed values (across all genes) from the in-
dividual fold changes of each gene, to center the fold change distribution
around 0. To filter out background contaminants, we used the CRAPOME
database (Mellacheruvu et al., 2013), which summarizes the number of pep-
tides identified for each protein across 343 control experiments. A protein
was considered a contaminant if it was present (based on two or more pep-
tides) acrossR20 control experiments, and filtered from subsequent analysis.
We supplemented our data with published proteomics data of WTAP pull-
down, obtained from Horiuchi et al. (2013). Then, we generated a network,
whereby a directed edge existed between bait A (METTL3, WTAP, METTL14,
YTHDF1, YTHDF2, YTHDF3, or m6A bait) and target B if the interaction
between the two, in any of the experiments, was associated with a fold
change >1.5.
M6A-Seq and Analysis of Internal m6A Methylation Sites
Isolation of total RNA, preparation of poly(A) RNA, the m6A pull-down
procedure, and library preparation were performed as detailed in Schwartz
et al. (2013). The computational analysis for internal sites is based on
Schwartz et al. (2013), with some modifications (Supplemental Experimental
Procedures).
Analysis of Putative Sites in the TSS
To identify putative mTSSs, we first counted the number of ‘‘left’’ reads origi-
nating at the first 50 bp of all annotated transcripts and recorded all positions in
which a stack of five or more reads originated. An initial collection of all sites
matching these criteria, and identified across any of the perturbations or
dynamic systems, was generated. To account for the presumed RT drop-
off, each site was assigned an ‘‘effective position,’’ which corresponded to
the stack position, unless that position did not harbor an adenosine and the
position immediately preceding it did, in which case it was assigned the posi-
tion preceding it. Sites were then aggregated based on genes and effective
positions, and for each position we summarized (1) total number of reads orig-inating from all input samples at each effective site, (2) total number of reads
from all IP samples, and (3) a fold change between (1) and (2).
Statistical Analysis
All statistical analyses and visualizations were performed in R. Sequence logos
were prepared using the SeqLogo package, and heatmaps were generated
with the gplots package.
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SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supplemental
Experimental Procedures, five figures, and five tables and can be found with
this article online at http://dx.doi.org/10.1016/j.celrep.2014.05.048.
AUTHOR CONTRIBUTIONS
S.S., M.R.M., A.R., and E.S.L. conceived most aspects of the study, acquired
all m6A data, analyzed the data, and wrote the paper. T.W., K.M., T.S.M., D.T.,
R.S., and N. Hacohen provided important technical assistance. M.J., P.M.,
and S.A.C. performed the protein mass spectrometry. G.G.B., E.F., and
M.E.P. performed nucleic acid mass spectrometry. D.C. performed iPSC ex-
periments, N. Habib, N.E.S., and F.Z. performed experiments differentiating
ES cell into NPCs.
ACKNOWLEDGMENTS
This work was supported by NHGRI CEGS P50 HG006193 (A.R.), U54
HG003067 (E.S.L), and Broad Institute Funds. A.R. was supported by an
NIH Pioneer Award and HHMI. S.S. was supported by a European Molecular
Biology Organization fellowship, and S.S. and D.C. were supported by
Human Frontier Science Program fellowships. M.J. was supported by fellow-
ships of the Swiss National Science Foundation for advanced researchers
(SNF) and the Marie Sklodowska-Curie IOF.
Received: January 28, 2014
Revised: April 7, 2014
Accepted: May 27, 2014
Published: June 26, 2014
REFERENCES
Agarwala, S.D., Blitzblau, H.G., Hochwagen, A., and Fink, G.R. (2012). RNA
methylation by the MIS complex regulates a cell fate decision in yeast. PLoS
Genet. 8, e1002732.
Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C., and Snyder,
M.; ENCODE Project Consortium (2012). An integrated encyclopedia of DNA
elements in the human genome. Nature 489, 57–74.
Bokar, J.A. (2005). The biosynthesis and functional roles of methylated nucle-
osides in eukaryotic mRNA. In Fine-Tuning of RNA Functions by Modification
and Editing, H. Grosjean, ed. (New York: Springer), pp. 141–177.
Bokar, J.A., Rath-Shambaugh, M.E., Ludwiczak, R., Narayan, P., and
Rottman, F. (1994). Characterization and partial purification of mRNA
N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA
methylation requires a multisubunit complex. J. Biol. Chem. 269, 17697–
17704.
Bokar, J.A., Shambaugh, M.E., Polayes, D., Matera, A.G., and Rottman,
F.M. (1997). Purification and cDNA cloning of the AdoMet-binding subunit
of the human mRNA (N6-adenosine)-methyltransferase. RNA 3, 1233–
1247.Cell Reports 8, 284–296, July 10, 2014 ª2014 The Authors 295
Bujnicki, J.M., Feder, M., Radlinska, M., and Blumenthal, R.M. (2002). Struc-
ture prediction and phylogenetic analysis of a functionally diverse family of
proteins homologous to the MT-A70 subunit of the human mRNA:m(6)A meth-
yltransferase. J. Mol. Evol. 55, 431–444.
Carninci, P., Sandelin, A., Lenhard, B., Katayama, S., Shimokawa, K., Pon-
javic, J., Semple, C.A., Taylor, M.S., Engstro¨m, P.G., Frith, M.C., et al.
(2006). Genome-wide analysis of mammalian promoter architecture and evo-
lution. Nat. Genet. 38, 626–635.
Clancy, M.J., Shambaugh, M.E., Timpte, C.S., and Bokar, J.A. (2002). Induc-
tion of sporulation in Saccharomyces cerevisiae leads to the formation of N6-
methyladenosine in mRNA: a potential mechanism for the activity of the IME4
gene. Nucleic Acids Res. 30, 4509–4518.
Davis, L., Barbera, M., McDonnell, A., McIntyre, K., Sternglanz, R., Jin, Q.,
Loidl, J., and Engebrecht, J. (2001). The Saccharomyces cerevisiae MUM2
gene interacts with the DNA replication machinery and is required for meiotic
levels of double strand breaks. Genetics 157, 1179–1189.
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M.,
Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec,
M., et al. (2012). Topology of the human and mouse m6A RNAmethylomes re-
vealed by m6A-seq. Nature 485, 201–206.
Duan, J., Shi, J., Ge, X., Do¨lken, L., Moy, W., He, D., Shi, S., Sanders, A.R.,
Ross, J., and Gejman, P.V. (2013). Genome-wide survey of interindividual dif-
ferences of RNA stability in human lymphoblastoid cell lines. Sci Rep 3, 1318.
Eisenberg, E., and Levanon, E.Y. (2003). Human housekeeping genes are
compact. Trends Genet. 19, 362–365.
Farrell, C.M., O’Leary, N.A., Harte, R.A., Loveland, J.E., Wilming, L.G., Wallin,
C., Diekhans,M., Barrell, D., Searle, S.M., Aken, B., et al. (2014). Current status
and new features of the Consensus Coding Sequence database. Nucleic
Acids Res. 42 (Database issue), D865–D872.
Furuichi, Y., Morgan, M., Shatkin, A.J., Jelinek, W., Salditt-Georgieff, M., and
Darnell, J.E. (1975). Methylated, blocked 5 termini in HeLa cell mRNA. Proc.
Natl. Acad. Sci. USA 72, 1904–1908.
Granadino, B., Campuzano, S., and Sa´nchez, L. (1990). The Drosophila mela-
nogaster fl(2)d gene is needed for the female-specific splicing of Sex-lethal
RNA. EMBO J. 9, 2597–2602.
Horiuchi, K., Kawamura, T., Iwanari, H., Ohashi, R., Naito, M., Kodama, T., and
Hamakubo, T. (2013). Identification of Wilms’ tumor 1-associating protein
complex and its role in alternative splicing and the cell cycle. J. Biol. Chem.
288, 33292–33302.
Keith, J.M., Ensinger, M.J., and Mose, B. (1978). HeLa cell RNA (20-O-methyl-
adenosine-N6-)-methyltransferase specific for the capped 50-end of
messenger RNA. J. Biol. Chem. 253, 5033–5039.
Little, N.A., Hastie, N.D., and Davies, R.C. (2000). Identification of WTAP, a
novel Wilms’ tumour 1-associating protein. Hum. Mol. Genet. 9, 2231–2239.
Liu, N., Parisien, M., Dai, Q., Zheng, G., He, C., and Pan, T. (2013). Probing N6-
methyladenosine RNA modification status at single nucleotide resolution in
mRNA and long noncoding RNA. RNA 19, 1848–1856.
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z.,
Deng, X., et al. (2014). A METTL3-METTL14 complex mediates mammalian
nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93–95.
Machnicka, M.A., Milanowska, K., OsmanOglou, O., Purta, E., Kurkowska, M.,
Olchowik, A., Januszewski, W., Kalinowski, S., Dunin-Horkawicz, S., Rother,296 Cell Reports 8, 284–296, July 10, 2014 ª2014 The AuthorsK.M., et al. (2013). MODOMICS: a database of RNA modification path-
ways—2013 update. Nucleic Acids Res. 41 (Database issue), D262–D267.
Mellacheruvu, D., Wright, Z., Couzens, A.L., Lambert, J.P., St-Denis, N.A., Li,
T., Miteva, Y.V., Hauri, S., Sardiu, M.E., Low, T.Y., et al. (2013). The CRAPome:
a contaminant repository for affinity purification-mass spectrometry data. Nat.
Methods 10, 730–736.
Mertins, P., Udeshi, N.D., Clauser, K.R., Mani, D.R., Patel, J., Ong, S.E., Jaffe,
J.D., and Carr, S.A. (2012). iTRAQ labeling is superior to mTRAQ for quantita-
tive global proteomics and phosphoproteomics. Mol. Cell. Proteomics 11,
014423.
Meyer, K.D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C.E., and Jaffrey,
S.R. (2012). Comprehensive analysis of mRNAmethylation reveals enrichment
in 30 UTRs and near stop codons. Cell 149, 1635–1646.
Ni, T., Corcoran, D.L., Rach, E.A., Song, S., Spana, E.P., Gao, Y., Ohler, U.,
and Zhu, J. (2010). A paired-end sequencing strategy to map the complex
landscape of transcription initiation. Nat. Methods 7, 521–527.
Ortega, A., Niksic, M., Bachi, A., Wilm, M., Sa´nchez, L., Hastie, N., and Valca´r-
cel, J. (2003). Biochemical function of female-lethal (2)D/Wilms’ tumor
suppressor-1-associated proteins in alternative pre-mRNA splicing. J. Biol.
Chem. 278, 3040–3047.
Ping, X.L., Sun, B.F., Wang, L., Xiao, W., Yang, X., Wang, W.J., Adhikari, S.,
Shi, Y., Lv, Y., Chen, Y.S., et al. (2014). Mammalian WTAP is a regulatory
subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24,
177–189.
Plessy, C., Bertin, N., Takahashi, H., Simone, R., Salimullah, M., Lassmann, T.,
Vitezic, M., Severin, J., Olivarius, S., Lazarevic, D., et al. (2010). Linking
promoters to functional transcripts in small samples with nanoCAGE and
CAGEscan. Nat. Methods 7, 528–534.
Robinson, S.W., Herzyk, P., Dow, J.A., and Leader, D.P. (2013). FlyAtlas: data-
base of gene expression in the tissues of Drosophila melanogaster. Nucleic
Acids Res. 41 (Database issue), D744–D750.
Schwanha¨usser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J.,
Chen, W., and Selbach, M. (2011). Global quantification of mammalian gene
expression control. Nature 473, 337–342.
Schwartz, S., Agarwala, S.D., Mumbach, M.R., Jovanovic, M., Mertins, P.,
Shishkin, A., Tabach, Y., Mikkelsen, T.S., Satija, R., Ruvkun, G., et al. (2013).
High-resolution mapping reveals a conserved, widespread, dynamic mRNA
methylation program in yeast meiosis. Cell 155, 1409–1421.
Wang, X., Lu, Z., Gomez, A., Hon, G.C., Yue, Y., Han, D., Fu, Y., Parisien, M.,
Dai, Q., Jia, G., et al. (2014a). N6-methyladenosine-dependent regulation of
messenger RNA stability. Nature 505, 117–120.
Wang, Y., Li, Y., Toth, J.I., Petroski, M.D., Zhang, Z., and Zhao, J.C. (2014b).
N6-methyladenosine modification destabilizes developmental regulators in
embryonic stem cells. Nat. Cell Biol. 16, 191–198.
Wei, C.M., Gershowitz, A., and Moss, B. (1975). Methylated nucleotides block
50 terminus of HeLa cell messenger RNA. Cell 4, 379–386.
Zheng, G., Dahl, J.A., Niu, Y., Fedorcsak, P., Huang, C.M., Li, C.J., Va˚gbø,
C.B., Shi, Y., Wang, W.L., Song, S.H., et al. (2013). ALKBH5 is a mammalian
RNA demethylase that impacts RNA metabolism and mouse fertility. Mol.
Cell 49, 18–29.
Cell Reports, Volume 8 
Supplemental Information 
Perturbation of m6A Writers Reveals  
Two Distinct Classes of mRNA  
Methylation at Internal and 5 Sites 
Schraga Schwartz, Maxwell R. Mumbach, Marko Jovanovic, Tim Wang, Karolina Maciag, 
G. Guy Bushkin, Philipp Mertins, Dmitry Ter-Ovanesyan, Naomi Habib, Davide 
Cacchiarelli, Neville E. Sanjana, Elizaveta Freinkman, Michael E. Pacold, Rahul Satija, 




RT-dropoff one nucleotide prior to the TSS 
 
To investigate the extent to which transcription start sites, in general, and methylated TSS, in 
particular, could be precisely identified based on our data, we first examined the distribution of 
>30,000 sites in mouse with >10 reads beginning at a specific site (across all conditions). We 
noted that this catalogue is enriched towards the first (annotated) position, as expected, but to an 
equal extent also at the second position, which was unexpected (Fig. S4A). To further address 
this, we analyzed the proportion of sites harboring an adenosine in the first or the second 
position, as a function of fold change over input. At the first position, we found a strong bias 
towards adenosine, as anticipated (Fig. S4B). However, at the second position, no such bias was 
noted. Instead, even when reads stacked at Position 2, the bias towards adenine was still at 
Position 1, and the magnitude of this bias was comparable to the one obtained when the stacks 
were at Position 1. Thus, the stacks at Positions 1 and 2 both appear to reflect methylations 
occurring at Position 1. The stacks at positions 2 likely reflect drop-off of the RT polymerase one 
nucleotide prior to reaching the 5’ terminus, possibly due to steric obstruction of the cap 
structure.  Virtually identical results were obtained when performing the same analysis in human 
(data not shown). 
 
As an independent source of validation that the sites preceding the stacks are the true TSSs, in 
cases in which the former lack an adenosine, note also the analysis presented in Fig. 5C-D, 




Correlation of mTSS s tate with transcript structure, sta bility and 
translation rates 
To gain further insight into the role of mTSSs, we examined the extent to which mTSS presence 
in a gene was associated with gene structure, RNA stability and translational efficiency. As our 
ability to detect mTSSs is biased towards more highly expressed genes, we used a randomly 
sampled control dataset matching the expression patterns of the mTSS harboring genes (but 
lacking mTSSs). Specifically, we compared sets of 2,891 human genes and 3,459 mouse genes 
containing an mTSS in four or more of the samples, to a roughly equal number of expression-
matched controls.  
Across the vast majority of datasets, mTSS presence was most strongly associated with 5’ UTR 
length, with genes harboring mTSSs having significantly shorter 5’ UTRs compared to their non-
methylated expression matched counterparts (Figs. S5A-C). This was observed using the full 
human and mouse datasets defined above (Fig. S5A-C) and when analyzing mTSSs identified in 
a specific condition (data not shown). Furthermore, a negative association with 5’ UTR length 
was observed when binning genes into 5 equally sized bins based on number of samples in which 
an mTSS was observed (a variable capturing both our confidence in the sites, and potentially the 
stoichiometry of modification at site)  (Fig. S5D-E).  
We also found a strong positive association between the presence of mTSS and translational 
efficiency (Fig. S5A-B), with genes harboring mTSSs exhibiting increased translational 
efficiencies compared to the expression matched controls (Fig. S5F-G). These effects were 
particularly strong when comparing our mouse dataset with translational efficiencies measured in 
mESC (Ingolia et al., 2011), but also observed in the human dataset when comparing with 
efficiencies measured in HeLa and HEK293 cells (Subtelny et al., 2014). We also observed a 
quantitative relationship between the number of conditions with mTSSs and translational 
efficiencies when using the binning approach described above (Fig. S5H and data not shown). 
As expression level, number of conditions in which an mTSS was observed, and 5’ UTR length 
are all correlated with each other, we used a linear model to predict translational efficiencies 
based on these three variables. In mouse, all variables significantly contributed to the model in 
this joint context (P<10-4 in all cases), whereas in human, the number of conditions in which 
mTSSs were observed ceased to remain significant. Finally, we note that in these analyses we 
noted only a negligible impact on RNA stability (Fig. S5A-B).   
Together, our data strongly supports an inverse association between 5’ UTR length and presence 
of mTSS, and moreover provides indications that mTSSs in genes with shorter 5’ UTR are 







Supplemental Figure S1 related to Figure 2. (A-D) Knockdown efficiency. (A-C) Shown are 
sample transcript knockdown levels (Y axis, expressed as proportion of average gene expression 
among non-perturbed samples), (upon perturbation of (A) WTAP or METTL3 (X axis) using 
shRNAs in mouse embryonic fibroblasts; (B) WTAP, METTL3, METTL14 using shRNAs in 
A549 cells, or (C) of WTAP, METTL3, METTL14 and KIAA1429 using siRNAs in human 
A549 cells. Transcript levels were determined based on TMM-normalized values from the 
(input) RNA-seq experiments. Boxplots present the distribution of the mean-normalized 
expression levels across all non-perturbed samples, with whiskers extending until the minimum 
and maximum of the distribution. Red dots indicate levels in the perturbed samples. Some red 
dots are additionally labelled with information on the experiment or hairpin used (D) Protein 
knockdown levels (by Western blots) following siRNA mediated depletion of METTL3, 
METTL14 and KIAA1429 from A549 cells. Cox4 was used as a loading control. (E,F) 
Identification of optimal set of consensus sites. For each of 64 pentamers harboring an AC at 
position 3-4 (NNACA), presented is a fold change quantifying enrichment in the set of 10,000 
top motifs in human (E) and mouse (F) over an equally sized shuffled dataset (Y-axis), along 
with a centrality score (X-axis) denoting the extent to which a motif is biased towards appearing 
at the very center of the detected peak (Methods). The motifs in red, scoring highest in both 
metrics and identical between human and mouse, were selected as the set of consensus motifs 
used throughout the manuscript. (G,H) Sequence features associated with false positive 
methylation sites. (G) Shown are the top scoring pentamers (first column) enriched in sites from 
the ‘false-positive’ cluster, along with their fold enrichment (second column) and a Bonferroni-
corrected P-value for a chi-squared test assessing their enrichment when comparing them to a set 
of WTAP-dependent sequences. (H) Sequence logo depicting a motif obtained from clustering 
all enriched pentamers with fold change >2 and corrected P value < 0.05. (I-K) Hallmarks of 
methylation in human A549 cells. Distributions of distances to consensus (I), lengths of internal 
exons harboring methylated sites (J), and sites across defined gene segments (K), for the sites in 
the three clusters (WTAP-dependent true positives: TP; False positives: FP; and TSS related: 
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genes harboring sites present only in brain (D) or only in DCs (E). (F,G) GO terms enriched in 
genes from (D) and (E), respectively. (H) Variability of POI scores across the two dynamic 
datasets in human (reprogramming into iPSCs and differentiation into NPCs) compared to 
variability of these scores across different experiments performed in A549 cells. For this 
analysis, we designated a control cohort of perturbation experiments in A549 cells in which we 
failed to observe a substantial impact on methylation (replicates of the shMETTL3, 
shMETTL14, and shGFP replicates). For each site in each experiment in this cohort, a 
distribution  of Z scores was calculated based on all remaining experiments in the cohort. 
Similarly, distributions of Z scores with respect to the control cohort were calculated for all other 
conditions, including the dynamic experiments and WTAP perturbation. Cumulative 
distributions of Z scores for a subset of these conditions are displayed. These analyses indicated 
the perturbations of WTAP as clear outliers, but the distributions of the remaining (I) Analysis as 
in (H) but for mouse. As cohort controls in this experiment, we made use of shMETTL(3), 
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Supplemental Figure 4 related to Figure 5. Anal ysis of methylated TSSs in human and  
mouse. (A) Distribution of relative positions of all mouse methylated sites harboring >10 reads 
(across all IP samples) with respect to annotated transcription start sites. (B) Proportion of 
positions containing an adenosine (Y axis), as a function of fold change between number of reads 
in the IP sample compared to the input sample (X axis), for 1,247 sites occurring at the very first 
annotated position (orange bars), and for 1,292 sites occurring at the second annotated position, 
showing separately for the latter the first position (light green bars) and the second (dark green 
bars). Error bars indicate the standard error of the proportion. (C) Sequence logo surrounding the 
human internal mTSSs (position >4) derived from 3,552 sites with log2 fold changes >4.5, as 
shown for mouse in Fig. 5b. (D) Proportion of methylated TSS sites (Y axis) in each of three 
equally sized fold-change bins (low, intermediate and high) detected in at least a given number 
of experiments among 13 experiments in mouse (X axis), including both the perturbation 
experiments (displayed in Fig. 2) and the experiments examining the dynamics of the 
methylations (displayed in Fig. 3). (E,F) Venn-diagrams showing the extent of overlap in 
detection of mTSSs across pluripotency reprogramming (human, E), and dendritic cell 
stimulation (mouse, F) and. Only sites with fold- changes >4 were considered as present in this 
analysis. Gene expression levels were not controlled for in this analysis. (G) Evaluation of 
saturation in mTSS detection in MEFs. Genes expressed above the 60th percentile were binned 
into 10 equally sized bins based on their expression (X axis). The proportion of genes for which 
an mTSS was identified is plotted for each bin (Y axis). Error bars – standard error of proportion. 
(H) As in (G), but quantifying the average number of unique mTSSs identified per transcript, as 
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pairwise comparison in human with the exception of the second and third bins, whereas in mouse 
only the pairwise interactions involving either of the extreme bins were significant.  
  
 Supplemental Table legends 
Supplemental Table 1, related to Figure 1: All protein-protein / RNA-protein putative 
interactions (fold changes >1.5) identified in this study. For each association, the bait and target 
are listed, the fold-change of the association, the number of quantified peptides and spectra, and 
in indication of abundance in the CRAPOME database, which was used for filtering purposes. 
Supplemental Table 2, related to Figures 2 and 3: Set of m6A peaks identified in this study. 
Genomic coordinates are provided for each peak, along with a UCSC id of the gene harboring it, 
transcription start and end sites of the gene, distance from the peak to the nearest consensus site, 
a classification score (based on a linear combination of dependence on WTAP and other features, 
see text) and a peak confidence category based on it, and a set of POI scores for the peak strength 
across the different experiments. 
Supplemental Table 3, related to Figure 5: Set of putative mTSS sites identified in human and 
mouse. Genomic coordinates and gene annotations are provided, along with number of 
experiments in which the given site obtained a fold-change exceeding 4, the overall fold change 
obtained for a site when summarizing IP and input reads across all experiments, and an indicator, 
for each condition, of whether or not a site was detected across each individual sample. 
Supplemental Table 4, related to Methods: Information pertaining to the proteomic 
experiments. Promoters and 3’ tags of constructs are provided, the nature of the control 
experiment against which the pulldown was quantified, and the number of replicates performed 
for the experiment.  
Supplemental Table 5, related to Methods: Information pertaining to the reagents used for the 
RNAi experiments. Product ids for the siRNAs and shRNAs are indicated.  
 
  
 Supplemental Experimental Procedures 
Mammalian cell culture 
Human 293T, A549 and p53-/- mouse embryonic fibroblast (MEF) cell lines were cultured in 
DMEM media supplemented with 10% FBS and 1% penicillin/streptomycin. 
  
Protein pull-down and mass-spectrometry 
Human 293T cells were grown in 10 cm plates to 70% confluency, and transfected with plasmids 
encoding 3’ tagged proteins (see Table S5 for details on epitopes) using Lipofectamine 2000 
(Life Technologies), following the manufacturer’s protocol. Cells were harvested 24 hours after 
transfection, pelleted by centrifugation and washed in PBS. The cell pellet was then resuspended 
in 600L of lysis buffer (150mM NaCl, 1.5mM MgCl2, 0.5% NP-40, 50mM Tris-HCl) with 
protease inhibitor (Roche). Cells were lysed on ice for 30 minutes and then centrifuged at 4 
degrees for 15 minutes at 10000 rpm. The supernatant was collected and BCA was used to 
estimate protein amounts. 50L of Dynabeads Protein G beads were washed in 250L of lysis 
buffer three times and then resuspended in 500L. They were then conjugated to Anti-HIS 
(GenScript) or Anti-V5 (Life Technologies) antibodies by rotating at 4 degrees for 2 hours. The 
beads were then washed three times in 250L of lysis buffer and then the lysate was added 
followed by a 2 hour rotation at 4 degrees. The beads were again washed six times in 500L of 
lysis buffer followed by an elution into elution buffer (50mM DTT, 25% LDS) at 80 degrees for 
10 minutes. 
 
Proteins were precipitated by adding -20C cold acetone to the eluate (acetone to eluate ratio 7:1) 
and overnight incubation at -20C. The proteins were pelleted by centrifugation at 20000xg for 
15min at 4C. The supernatant was discarded and the pellet was left to dry by evaporation. The  
protein pellet was reconstituted in 50 l lysis buffer (8M Urea, 75mM NaCl, 50mM Tris/HCl pH 
8.0, 1mM EDTA) and protein concentrations were determined by BCA assay (Pierce, Rockford, 
IL). 5 to 10g total protein per affinity enrichment were obtained condition. Disulfide bonds 
were reduced with 5mM dithiothreitol and cysteines were subsequently alkylated with 10mM 
iodoacetamide. Samples were diluted 1:4 with 50mM Tris/HCl (pH 8.0) and sequencing grade 
modified trypsin (Promega, Madison, WI; V5113) was added in an enzyme-to-substrate ratio of 
1:50. After 16h of digestion, samples were acidified with 1% formic acid (final concentration). 
Tryptic peptides were desalted on C18 StageTips according to (Rappsilber et al., 2007) and 
evaporated to dryness in a vacuum concentrator. 
 
Desalted peptides were labeled with the iTRAQ reagent according to the manufacturer’s 
instructions (AB Sciex, Foster City, CA) and to (Mertins et al., 2012). Briefly, for 10g of 
peptide 0.33 units of iTRAQ reagent was used. Peptides were dissolved in 10l of 0.5M TEAB 
pH 8.5 solution and the iTRAQ reagent was added in 25l of ethanol. After 1h incubation the 
reaction was stopped with 50mM Tris/HCl (pH 8.0). Differentially labeled peptides were mixed 
and subsequently desalted on C18 StageTips (Rappsilber et al., 2007) and evaporated to dryness 
in a vacuum concentrator. Peptides were reconstituted in 20l 3% MeCN/0.1% formic acid. LC-
MS/MS analysis was performed as described in (Mertins et al., 2013).  
 
 
Gene silencing using siRNAs 
Human A549 cells were plated in 6-well plates at 20% confluency. siRNAs targeting the relevant 
genes (Table S8) were transfected using Lipofectamine RNAiMAX (Life Technologies) 
following the manufacturer’s protocols, with two additional siRNA boosts delivered at 48 and 96 
hours following transfection. Cells were harvested at 144 hours.  
 Gene silencing using shRNA 
Human A549 cells and p53-/- mouse fibroblasts were plated in 6-well plates at 20% confluency. 
Cells were infected with shRNAs targeting the relevant genes in human and mouse (Table S5), 
in media supplemented with 8g/mL polybrene followed by centrifugation at 2200 rpm for 30 
minutes. 18 hours later media was removed and replaced with media supplemented with 2g/mL 
puromycin. Cells were harvested 72-96 hours later. For identifying effective shRNAs, we 
screened – for each gene – 4-6 shRNAs available through the Broad RNAi Consortium (TRC), 
and quantified decreases in expression level using qPCR; We selected 1-2 shRNAs for which we 
observed maximal decreases in expression level, and for which these levels were below 30% 
(typically even less) of WT expression levels. 
 
HPLC-MS of nucleosides 
50 ul oligo-dT selected mRNA fractions and flowthrough RNA fractions were digested with 2 
units of P1 nuclease (US biological) at 50oC in 50 mM ammonium acetate buffer pH 5.3 with 5 
mM zinc chloride for 2 hours. Nucleotides were dephosphorylated by addition of 5 units of CIP 
(New England Biolabs) for another 2 hours at 37oC, and then diluted 1:10 in acetonitrile. 
Metabolome data were acquired on a Dionex UltiMate 3000 UPLC coupled to a Q Exactive 
orbitrap mass spectrometer (Thermo Fisher Scientific). Separation was performed on a Luna 3 
µm Amino Column (150 x 2 mm; Phenomenex) using a gradient of 5 mM ammonium acetate + 
0.2% v/v ammonium hydroxide, pH 10, and acetonitrile. The mass spectrometer was operated in 
the targeted SIM mode with DZA as the internal standard. Metabolites were identified by 
accurate mass (+/- 5 ppm) and retention time. Peak areas were calculated with QuanBrowser 
(Thermo Fisher Scientific).  
 
M6A-Seq 
Isolation of total RNA, preparation of poly(A) RNA, the m6A pull-down procedure, and library 
preparation were performed as detailed in (Schwartz et al., 2013). Anti-m6A antibodies were 
either obtained from Synaptic Systems (catalog number 202 003) or generously provided by 
New England Biolabs (Meyer et al., 2012). Samples were sequenced on Illumina HiSeq 2000 
and HiSeq 2500 platforms in paired end mode, with 25-30 nucleotides sequenced from each of 
the two ends. 
 
Read alignment  
Reads were initially mapped against a set of human or mouse ribosomal RNA (rRNA) sequences 
using Bowtie (version 0.12.7), and all reads aligning to the rRNA were discarded. All remaining 
reads were aligned against the human (hg19) or mouse (mm9) genome using Tophat (version 
1.4.1). Parameters used were ‘--max-multihits 1 –prefilter-multihits’ and ‘–transcriptome-index’, 
for which we assigned a pre-indexed version of the relevant transcriptomes, based on the UCSC 
Known Genes set of annotations. An in-house script was then used to project all reads aligning to 
the genome upon the human and mouse transcriptomes. Only reads fully matching a transcript 
structure, as defined by the ‘UCSC Known Genes’ transcriptome annotation, were retained. Such 
reads were computationally extended in transcriptome space from the beginning of the first read 
to the end of its mate, and coverage in transcriptome-space was calculated for each nucleotide 
across all transcripts.  
 
Detection of putative m6A sites 
Putative m6A sites were identified using a 3 step-approach, consisting of: (1) Examination of the 
IP sample, to identify regions within genes in the IP samples that were enriched in comparison to 
background gene levels; (2) Comparison of IP sample with input sample, to ensure that these  
regions were not enriched in corresponding input samples; and (3) Comparison across multiple 
replicates of IP and input samples. Below we provide a detailed description of these steps, which 
is very similar to the approach used in (Schwartz et al., 2013), with a few extensions and 
modifications. 
 
(1) Peak detection within genes. To search for enriched peaks in the m6A IP samples, we 
scanned each gene using sliding windows of 100 nucleotides with 50 nucleotides overlap. Each 
window was assigned a Peak Over Median (POM) score, defined as mean coverage in the 
window / median coverage across the gene. Windows with POM scores greater than 4 (i.e., 
greater than 4-fold enrichment) and with a mean coverage >10 reads were retained. Overlapping 
windows were merged together, and for each disjoint set of windows in transcriptome space we 
recorded its start, end, and peak position, corresponding to the position with the maximal 
coverage across the window.  
(2) Ensuring that peaks w ere absent in input.  We repeated the procedure in step (1) for the 
input sample. We eliminated from all subsequent analysis all windows that were detected in both 
step (1) and (2).  
 
(3) Comparison of m ultiple samples and criteria for WTAP-dependence.  To compare 
between different perturbations and/or conditions, we applied the following strategy. We first 
merged the coordinates of all windows from all samples passing step (1) and (2), to define a set 
of disjoint windows passing these filters in at least one of the samples. For each such window, 
we recalculated the peak start, end, peak position, and POM score (as defined above) across each 
of the samples using the approach in step (1). In addition, for each window we calculated a Peak 
Over Input (POI) score, corresponding to the fold-change of coverage across the window in the 
IP sample over the coverage in the input sample. To account for differences in sample depth, we  
estimated the mean difference between IP and input samples across the 500 most highly 
expressed genes, which we used as an estimate for background. We subtracted this background 
from the POI score. Of note, the POM and POI scores generally correlated well with each other; 
nevertheless, we empirically found that in some cases it was more informative to filter based on 
the one than on the other. 
 
For each sample, we then calculated the maximal POI across all samples, as well as the number 
of samples in which the POI scores were ≥3. As a measure of WTAP dependence, we calculated 
for each site the difference between the mean POI scores across non-perturbed samples (e.g., 
shGFP, shRFP, siControl) and the WTAP perturbed counterparts (e.g., shWTAP, siWTAP), and 
required that these reflect a 50% or 100% increase compared to the non-perturbed samples 
(precise thresholds are indicated in the figure legends of the respective experiments).  
 
Sites were grouped assigned into one of five gene segments: (1) TSS segment, comprising the 
first 200nt of each gene, (2) 5’ UTR segment, comprising all non-TSS segment 5’ UTR 
positions, (3) stop codon segment, comprising all positions within 200nt of the annotated stop 
codon, (4) CDS segment, comprising all non-stop segment positions in the CDS, and (5) 3’UTR 
segment, comprising all non-stop segment 3’ UTR positions. 
 
HUES9 human pluripotent stem cell and neural progenitor culture 
For HUES9 (Harvard Stem Cell Institute iPS Core Facility) human pluripotent stem cells, 
standard stem cell media consists of mTeSR1 (STEMCELL Technologies) supplemented with 
1X Normocin (InvivoGen). Cells were maintained using the Enhanced Culture Protocol 
described elsewhere (Schinzel et al., 2011). For HUES9 human neural progenitor cells (NPCs), 
standard media consists of 50% N2 media and 50% B27 media (all from Life Technologies  
unless indicated otherwise). N2 media: DMEM-F12 supplemented with 1X N2 supplement, 
5g/ml insulin, 100M β-mercaptoethanol, 1X Glutamax, 1X non-essential amino acids, 1X 
Normocin (InvivoGen). B27 media: Neurobasal supplemented with 1X B27 supplement, 1X 
sodium pyruvate, 1X Glutamax, 5ml non-essential amino acids, 1X Normocin (InvivoGen). All 
culture dishes were coated with Geltrex (1:100 in DMEM) for at least 1 hour at 37C. 
 
NPCs were differentiated from HUES9 cells using standard dual SMAD differentiation 
(Chambers et al., 2009; Shi et al., 2012). Briefly, stem cells were passaged the day before 
differentiation at sufficient density to achieve 100% confluence within 24 hours. Once at 100% 
confluence, media was switched to standard neural progenitor media supplemented with 
200ng/mL rhNoggin (R&D Systems) and 10μM SB431542 (Stemgent) and changed daily for the 
first 10 days of neural induction. After 10 days, cells were passaged and replated at 200,000 cells 
per cm2 in standard neural progenitor media supplemented with 10μM Y-27632. Twenty-four 
hours after passaging, media was replaced with standard neural progenitor media alone. Between 
12 and 17 days after neural induction, cultures were monitored closely to verify formation of 
neural rosettes. After this stage, NPCs and neurons were split as necessary (with 10μM Y-27632) 
until day 25 post-induction, when cells were rinsed once in PBS and then lysed in RLT Plus with 
β-mercaptoethanol, snap-frozen on dry ice, and stored at -80C until RNA extraction. 
 
Mice brain samples 
Male mice were sacrificed at the age of 3 months, and their hippocampus was micro-dissected. 
Mice embryos were sacrificed at the age of E16, and their brain tissue was extracted. Brain 
samples from siblings were pooled together (6-8 animals per litter). The brain tissue was inserted 
after dissection immediately into RNA-later stabilization reagent (Qiagen), kept in 4C for 24 
hours, and then transferred to -80C for storage. All experiments were performed in compliance  
with the institutional guidelines and were reviewed and approved by the Institutional Animal Use 
and Care Committee (IAUCC) of the Massachusetts Institute of Technology (Protocol number: 
0411-040-14). 
 
Bone marrow derived dendritic cells 
Cultures of bone marrow derived dendritic cells (BMDCs from 6-8 week old female C57BL/6J 
mice) were prepared as previously described (Amit et al., 2009). At 9 days of in vitro culture, 
cells were stimulated with lipopolysaccharide (LPS, Invivogen) as previously described (Amit et 
al., 2009).  Cells were harvested either at time of stimulation, or 3 and 6 hours later. All 
experiments were performed in compliance with the institutional guidelines and were reviewed 
and approved by the Institutional Animal Use and Care Committee (IAUCC) of the 
Massachusetts Institute of Technology (Protocol number: 0612-058-15).  
 
Induction of pluripotency 
hTERT immortalized fibroblasts differentiated from iPSCs harboring a Doxycycline-inducible 
polycistronic OCT4-KLF4-MYC-SOX2 (Cacchiarelli et al., manuscript in preparation) were 
collected in growth conditions in absence of Doxycycline, upon 5 days of Doxycycline 
treatment, or in absence of Doxycycline upon derivation of the iPSC line. Reprogramming 
conditions are as described in (Chan et al., 2009). 
 
Consensus sequence 
We defined the m6A consensus sequence as a motif matching any of the following sequences: 
GGACA, GGACU, GGACC, GAACU, AGACU, AGACA and UGACU. This set of sequences 
was obtained by taking a 60nt region surround the 10,000 top scoring peaks in human and mouse 
(‘test’ sequences), and mapping all NNACN pentamers within this region. As random controls,  
we scrambled this set of sequences. For each pentamer, we quantified the fold-change in 
abundance between the test and control sequences. In parallel, as methylated motifs are biased to 
be in the very center of the 60nt region, we scored each pentamer based on its centrality. For 
each pentamer, we then generated 12-bin histograms of the distributions of distances from the 
center of the sequence, and divided the density at the center of the histogram with the mean 
densities in the first and last bin (‘centrality score’). Plotting each pentamer as a function of these 
two metrics yielded the above defined set enriched in both metrics (and which was identical in 
human and mouse) (Fig. S1E-F). 
 
Overlap of mTSS and CAGE data 
For examining the overlap between our set of mTSSs and CAGE data, we used data from a 
CAGE experiment performed on long, cellular, poly(A) mRNA in the ENCODE project 
(Consortium et al., 2012). Processed data summarizing the number of reads beginning at each 
genomic position was downloaded from http://ccg.vital-
it.ch/mga/hg19/encode/GSE34448/GSE34448.html (A549_cell_longPolyA_rep1.sga). This data 




Half-lives for mouse mRNAs in NIH3T3 fibroblasts were obtained from (Schwanhausser et al., 
2011). Half-lives for human mRNAs were obtained based on (Duan et al., 2013), which 
measured half-lives across 7 human HapMap lymphoblastoid cell lines. We used the median 
value across these cell lines as an estimate of half-life.  
 
Statistical analysis  
All statistical analyses and visualizations were performed in R: Sequence logos were prepared 
using the SeqLogo package (Bembom, 2011), heatmaps were generated using the gplots package 
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